查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1475015

全球合成脂質市場評估：依形式、應用、地區、機會、預測（2017-2031）

Synthetic Lipids Market Assessment, By Form [Solid, Liquid], By Application [Personal Care and Cosmetics, Pharmaceuticals, Food], By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 229 Pages | 商品交期: 3-5個工作天內

價格

全球合成脂質市場規模預計將從 2023 年的 25.6 億美元增至 2031 年的 39.3 億美元，預計 2024-2031 年的複合年增長率為 5.5%。 個人護理產品和化妝品中合成脂質的使用不斷增加以及製藥行業的快速擴張支持了市場的擴張。

製藥業對合成脂質的需求不斷增加是擴大全球合成脂質市場規模的主要因素之一。 製藥業對合成脂質的需求成長可歸因於以下事實：合成脂質由單一脂質組成，並以其品質而聞名，與天然脂質相比具有多種優勢。 另外，組織來源的脂質通常是牛或蛋來源的脂質的組合。 與組織來源的脂質不同，合成脂質不存在蛋白質或病毒污染的風險，且不存在批次間的差異。 此外，透過優化純化技術和製造流程以及選擇高品質的起始材料可以提高合成脂質的純度。 因此，製藥業的需求不斷增加，支持了市場的擴大。

與各國政府和市場領導者的合作進一步為市場提供了利潤豐厚的成長機會。 例如，2022 年 6 月，領先的特種化學品公司之一贏創宣佈與美國政府合作投資 2.2 億美元建設脂質生產設施，以生產基於 mRNA 的治療藥物。 Chippecanoe 位於印第安納州拉斐特的工廠預計將實現靈活的脂質生產。 該項目計劃於2023年初動工建設，並於2025年投入營運。

化妝品及個護產業擴張帶動市場需求

世界各地個人對化妝品和個人護理產品的投資不斷增加，正在為市場創造利潤豐厚的成長機會。 例如，根據《富比士》2023年發表的文章，2022年美國化妝品市場規模約500億美元。 預計這種增長將加強對合成脂質的需求並推動預測期內的市場擴張。 這種市場擴張可歸因於膽固醇的特性，膽固醇對於形成健康的皮膚屏障至關重要。 它們通常被添加到修復屏障保濕霜中，以幫助它們有效發揮作用。 定期修復皮膚屏障對於防止經皮水分流失並保持過敏原、刺激物和細菌遠離皮膚至關重要。 對虐待動物的認識不斷增強以及對動物福利的擔憂正在促使世界各地的人們轉向純素產品。 這些擔憂推動了對個人護理產品和化妝品的需求，並且由於植物不會產生合成膽固醇，因此推動了對合成膽固醇的需求並支持市場擴張。 各種化妝品和個人護理製造商越來越多地採用合成膽固醇來為客戶提供純素屏障修復保濕霜，這增加了市場需求。

食品業不斷增長的產品需求推動了市場需求

對商業母乳脂肪替代品 (HMFS) 的需求不斷增長，對市場成長產生了積極影響。 母乳脂肪是主要的能量來源，約佔嬰兒每日熱量攝取的50%。 它也是脂溶性維生素和重要脂肪酸的重要來源。 棕櫚酸和油酸是母乳脂肪中的主要脂肪酸，分別佔25%和40%。

然而，棕櫚酸（一種水解遊離脂肪酸）會與新生兒生長所需的礦物質和鈣形成不溶性鹽，並透過糞便排出，導致便秘並抑制鈣的吸收。 因此，在配製HMFS時，必須調整棕櫚酸的組成和用量。 市售的 HMFS 是一種含有脂肪酸的合成脂質，分佈與人類乳脂肪相當。 因此，它是合成嬰兒配方奶粉的重要原料。 例如，美國國際貿易委員會估計，全球嬰兒配方奶粉出口額為96億美元，出口量為100萬噸（均不包括歐盟內部貿易）。 因此，嬰兒配方奶粉需求的增加正在推動合成脂質的需求，推動市場成長。

本報告研究和分析了全球合成脂質市場，提供市場規模和預測、市場動態以及主要參與者的現狀和前景。

目錄

第一章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第 4 章顧客回饋

  • 市場認知度與產品訊息
  • 品牌知名度與忠誠度
  • 購買決策時考慮的因素
  • 購買頻率
  • 購買介質

第五章全球合成脂質市場展望（2017-2031）

  • 市場規模與預測
    • 金額
    • 數量
  • 依形狀
    • 固體
    • 液體
  • 依用途
    • 個人護理/化妝品
    • 醫學
    • 食物
  • 依地區
    • 北美
    • 南美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 市佔率：依公司劃分（2023 年）

第 6 章全球合成脂質市場前景：依地區劃分（2017-2031 年）

  • 北美
    • 市場規模與預測
    • 依形狀
    • 依用途
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 南美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第七章供給面分析

  • 生產能力：依公司劃分
  • 生產：依公司劃分
  • 營運效率：依公司劃分
  • 主要工廠地點（最多 25 個地點）

第 8 章市場地圖（2023 年）

  • 依形狀
  • 依用途
  • 依地區

第九章宏觀環境與產業結構

  • 需求與供給分析
  • 進出口分析
  • 供應鏈分析
  • PESTEL 分析
  • 波特五力分析

第 10 章市場動態

  • 生長促進因素
  • 抑製成長的因素（問題、限制因素）

第十一章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析（2023 年）
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家市場公司）
  • 專利分析（如果適用）

第十二章價格分析

第 13 章案例研究

第14章主要公司展望

  • CordenPharma
  • Sigma-Aldrich (Merck Group)
  • Merck Millipore
  • Avanti Polar Lipids, Inc
  • Lipoid GmbH
  • NOF EUROPE GmbH
  • Croda Pharma
  • NucleoSyn
  • Evonik Industries AG
  • ABITEC Corporation

第 15 章策略建議

第16章關於我們公司，免責聲明

Product Code: MX11282

Global synthetic lipids market is projected to witness a CAGR of 5.5% during the forecast period 2024-2031, growing from USD 2.56 billion in 2023 to USD 3.93 billion in 2031F. The market expansion is supported by the increasing utilization of synthetic lipids in personal care and cosmetic products and rapid expansion of pharmaceutical sector.

The increasing demand for synthetic lipids by the pharmaceutical sector is one of the major factors augmenting the global synthetic lipids market size. The rising requirement of synthetic lipids by the pharmaceutical sector can be attributed to the various advantages offered by the synthetic lipids over their natural counterparts as they consist of a single lipid, the quality of which is known. Also, tissue-derived lipids are usually a combination of bovine-derived or egg-derived lipids. Synthetic lipids, unlike tissue-derived lipids, do not possess a risk of protein or viral contamination or show batch-to-batch variability. Additionally, the purity of synthetic lipids can be enhanced by optimizing the purification techniques and manufacturing processes and by selecting starting materials with superior quality. Thus, boosting their demand from the pharmaceutical sector and supporting the market expansion.

Collaborations between different governments and leading players of the market are further providing lucrative growth opportunities to the market. For instance, in June 2022, Evonik, one of the leading specialty chemicals companies announced an investment of USD 220 million in partnership with the government of the United States to build lipid production facility for producing mRNA-based therapies. The Tippecanoe site in Lafayette, Indiana is expected to ensure flexible lipid production. The construction for the project commenced in early 2023 and is expected to go onstream in 2025.

Expansion of the Cosmetics and Personal Care Industry Boosts Market Demand

The increasing investments by individuals in various regions across the globe in cosmetics and personal care products is providing lucrative growth opportunities to the market. For instance, according to an article published by Forbes in 2023, the value of the cosmetics market in the United States was approximately USD 50 billion in 2022. The growth will bolster the demand for synthetic lipids and aid the expansion of the market over the forecast period. The expansion can be attributed to the essential nature of cholesterol in making a healthy skin barrier. They are often added to barrier repair moisturizers to function effectively. Regular repair of the skin barrier is essential for preventing trans-dermal water loss and for keeping allergens, irritants, and bacteria away from the skin. Due to the growing awareness about animal cruelty and rising concerns about animal welfare, individuals across the globe are switching to vegan products due to increasing consciousness. Such concerns propel the requirement for personal care products and cosmetics and support the market expansion as they boost the demand for synthetic cholesterol as plants do not produce it. The increasing adoption of synthetic cholesterol by various cosmetic and personal care manufacturers to provide vegan barrier repair moisturizers to their customers is augmenting the market demand.

Increasing Product Requirement from Food Industry Boosts Global Synthetic Lipids Market Demand

The rising requirement for commercial human milk fat substitutes (HMFSs) is positively influencing the growth of the market. Human milk fat provides approximately 50% of babies' daily calorie intake and is their primary energy source. It is also an essential source of fat-soluble vitamins and vital fatty acids. Palmitic acid and oleic acid are the main fatty acids available in human milk fat, constituting up to 25% and 40%, respectively.

However, palmitic acid, a hydrolyzed free fatty acid forms an insoluble salt with the minerals and calcium that are required by the newborns for growth is excreted in feces, causing constipation, and preventing the absorption of calcium. Hence, it is essential to regulate the composition and amount of palmitic acid while formulating HMFSs. Commercial HMFSs are synthetic lipids that have a distribution comparable to that of human milk fat and contain fatty acids. Thus, making it an essential raw material in synthesis of infant food products (formula). For instance, according to the U.S. International Trade Commission estimates, the global infant and child formula exports were valued at USD 9.6 billion with a volume of 1 million mt (these figures exclude the intra-EU trade). Therefore, the increase in the requirement for infant formula is boosting the demand for synthetic lipids and aiding the market growth.

North America to Hold Significant Share in the Market

The strong presence of leading market players and rapid expansion of pharmaceutical and food sectors in the region are boosting the growth of North America synthetic lipids market. According to the U.S. Department of Agriculture, food, agriculture, and related industries contributed approximately USD 1.420 trillion to the GDP of the United States in 2022. Additionally, estimates suggest that the United States pharmaceutical industry generated USD 550 billion in 2021 in revenue. Due to the growth and expansion in food and pharmaceutical sectors in the region, the requirement for synthetic lipids is increasing as they find various applications in the sector. Owing to the success of mRNA vaccines, Moderna, a United States based biotechnology company is now working on the development of vaccines for a host of diseases including Zika, Malaria, tuberculosis, and HIV. Hence, the increase of research and development activities amongst leading pharmaceutical and biotechnological companies in the region will further boost the requirement for synthetic lipids, thus propelling the growth of the market.

Solid Synthetic Lipids Account for Significant Global Synthetic Lipids Market Share

The growth of the segment is supported by the increasing research activities conducted by various leading research institutions across the globe on solid lipid nanoparticles. For instance, these institutes include, the Department of Chemistry, Indian Institute of Technology Kharagpur. The researchers evaluated the stability and physicochemical characterizations and in vitro evaluations of CUR-loaded solid nanoparticles that were prepared with the help of biocompatible synthetic lipids. The solid lipid nanoparticles are showing promising results as drug delivery vehicles for ensuring the delivery of different drug types, especially poorly water-soluble drugs. The solid lipid nanoparticles can play an essential role in ensuring the delivery of curcumin in the disease sites with enhanced overall effects and improved bioavailability.

Rising Requirements from the Pharmaceutical Sector Aids Global Synthetic Lipids Market Growth

The increasing utilization of synthetic lipids for development of RNA therapies is boosting the growth of the market. MRNA-based systems are deployed for development of vaccines where viral proteins are identified as the potential candidates for vaccines. These systems are preferred as they are less prone to anti-vector immunity and genome integration. For instance, the recent success of BioNTech and Moderna has now resulted in the increase of clinical and preclinical studies of mRNA to other therapeutic and infectious disease applications, thus boosting the growth of the market. Moreover, the consistency and quality of lipids utilized in different pharmaceutical formulations is extremely essential. Lipid quality, type, and source are carefully considered prior to the initiation of the process as they directly impact the properties and impurity profile of the final drug. Furthermore, the choice of lipid impacts the particle characteristics, including release properties, structure, and stability. It is essential to control various impurities such as trans fatty acids in lipids as they can alter the RNA release and particle stability. Thus, synthetic lipids offer various advantages as opposed to natural lipids because the former is derived from a single lipid with known quality, and the chances of batch-to-batch variability are decreased. It, in turn, augments the demand for synthetic lipids and supports the growth of the market.

Key Players Landscape and Outlook

Global synthetic lipids market expansion is supported by increasing investments by leading market players towards the development of new lipid manufacturing plants. For instance, in March 2023, Evonik announced the opening of a new lipid manufacturing facility in Hanau, Germany. According to the company's chemical specialist the lipids produced will be used for gene therapies and RNA drugs aimed at cancer and infectious diseases, among others. The facility supports the production of proprietary as well as custom lipids. Such investments are expected to bolster synthetic

lipids' production, supporting the market's expansion.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Market Awareness and Product Information
  • 4.2.Brand Awareness and Loyalty
  • 4.3.Factors Considered in Purchase Decision
    • 4.3.1.Brand Name
    • 4.3.2.Quality
    • 4.3.3.Quantity
    • 4.3.4.Price
    • 4.3.5.Product Specification
    • 4.3.6.Form Specification
    • 4.3.7.Shelf Life
    • 4.3.8.Availability of Product
  • 4.4.Frequency of Purchase
  • 4.5.Medium of Purchase

5.Global Synthetic Lipids Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
    • 5.1.2.By Volume
  • 5.2.By Form
    • 5.2.1.Solid
    • 5.2.2.Liquid
  • 5.3.By Application
    • 5.3.1.Personal Care and Cosmetics
    • 5.3.2.Pharmaceuticals
    • 5.3.3.Food
  • 5.4.By Region
    • 5.4.1.North America
    • 5.4.2.South America
    • 5.4.3.Europe
    • 5.4.4.Asia-Pacific
    • 5.4.5.Middle East & Africa
  • 5.5.By Company Market Share (%), 2023

6.Global Synthetic Lipids Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
      • 6.1.1.2.By Volume
    • 6.1.2.By Form
      • 6.1.2.1.Solid
      • 6.1.2.2.Liquid
    • 6.1.3.By Application
      • 6.1.3.1.Personal Care and Cosmetics
      • 6.1.3.2.Pharmaceuticals
      • 6.1.3.3.Food
    • 6.1.4.United States*
      • 6.1.4.1.Market Size & Forecast
        • 6.1.4.1.1.By Value
        • 6.1.4.1.2.By Volume
      • 6.1.4.2.By Form
        • 6.1.4.2.1.Solid
        • 6.1.4.2.2.Liquid
      • 6.1.4.3.By Application
        • 6.1.4.3.1.Personal Care and Cosmetics
        • 6.1.4.3.2.Pharmaceuticals
        • 6.1.4.3.3.Food
    • 6.1.5.Canada
    • 6.1.6.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East & Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Supply Side Analysis

  • 7.1.Capacity, By Company
  • 7.2.Production, By Company
  • 7.3.Operating Efficiency, By Company
  • 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

  • 8.1.By Form
  • 8.2.By Application
  • 8.3.By Region

9.Macro Environment and Industry Structure

  • 9.1.Supply Demand Analysis
  • 9.2.Import Export Analysis
  • 9.3.Supply Chain Analysis
  • 9.4.PESTEL Analysis
    • 9.4.1.Political Factors
    • 9.4.2.Economic System
    • 9.4.3.Social Implications
    • 9.4.4.Technological Advancements
    • 9.4.5.Environmental Impacts
    • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 9.5.Porter's Five Forces Analysis
    • 9.5.1.Supplier Power
    • 9.5.2.Buyer Power
    • 9.5.3.Substitution Threat
    • 9.5.4.Threat from New Entrant
    • 9.5.5.Competitive Rivalry

10.Market Dynamics

  • 10.1.Growth Drivers
  • 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

  • 11.1.Competition Matrix of Top Five Market Leaders
  • 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4.SWOT Analysis (For Five Market Players)
  • 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

  • 14.1.CordenPharma
    • 14.1.1.Company Details
    • 14.1.2.Key Management Personnel
    • 14.1.3.Products & Services
    • 14.1.4.Financials (As reported)
    • 14.1.5.Key Market Focus & Geographical Presence
    • 14.1.6.Recent Developments
  • 14.2.Sigma-Aldrich (Merck Group)
  • 14.3.Merck Millipore
  • 14.4.Avanti Polar Lipids, Inc
  • 14.5.Lipoid GmbH
  • 14.6.NOF EUROPE GmbH
  • 14.7.Croda Pharma
  • 14.8.NucleoSyn
  • 14.9.Evonik Industries AG
  • 14.10.ABITEC Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 3.Global Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 4.Global Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 5.Global Synthetic Lipids Market Share (%), By Region, 2017-2031F
  • Figure 6.North America Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 7.North America Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 8.North America Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 9.North America Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 10.North America Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 11.United States Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 12.United States Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 13.United States Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 14.United States Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 15.Canada Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.Canada Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 17.Canada Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 18.Canada Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 19.Mexico Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 20.Mexico Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 21.Mexico Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 22.Mexico Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 23.Europe Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 24.Europe Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 25.Europe Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 26.Europe Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 27.Europe Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 28.Germany Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 29.Germany Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 30.Germany Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 31.Germany Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 32.France Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 33.France Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 34.France Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 35.France Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 36.Italy Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 37.Italy Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 38.Italy Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 39.Italy Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 40.United Kingdom Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.United Kingdom Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 42.United Kingdom Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 43.United Kingdom Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 44.Russia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 45.Russia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 46.Russia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 47.Russia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 48.Netherlands Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 49.Netherlands Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 50.Netherlands Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 51.Netherlands Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 52.Spain Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Spain Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 54.Spain Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 55.Spain Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 56.Turkey Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 57.Turkey Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 58.Turkey Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 59.Turkey Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 60.Poland Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 61.Poland Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 62.Poland Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 63.Poland Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 64.South America Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.South America Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 66.South America Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 67.South America Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 68.South America Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 69.Brazil Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 70.Brazil Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 71.Brazil Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 72.Brazil Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 73.Argentina Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 74.Argentina Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 75.Argentina Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 76.Argentina Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 77.Asia-Pacific Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 78.Asia-Pacific Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 79.Asia-Pacific Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 80.Asia-Pacific Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 81.Asia-Pacific Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 82.India Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.India Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 84.India Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 85.India Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 86.China Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 87.China Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 88.China Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 89.China Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 90.Japan Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 91.Japan Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 92.Japan Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 93.Japan Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 94.Australia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.Australia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 96.Australia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 97.Australia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 98.Vietnam Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 99.Vietnam Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 100.Vietnam Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 101.Vietnam Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 102.South Korea Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 103.South Korea Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 104.South Korea Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 105.South Korea Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 106.Indonesia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 107.Indonesia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 108.Indonesia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 109.Indonesia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 110.Philippines Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 111.Philippines Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 112.Philippines Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 113.Philippines Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 114.Middle East & Africa Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 115.Middle East & Africa Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 116.Middle East & Africa Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 117.Middle East & Africa Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 118.Middle East & Africa Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 119.Saudi Arabia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 120.Saudi Arabia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 121.Saudi Arabia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 122.Saudi Arabia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 123.UAE Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 124.UAE Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 125.UAE Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 126.UAE Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 127.South Africa Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 128.South Africa Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 129.South Africa Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 130.South Africa Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 131.By Form Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 132.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 133.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023